Virtus LifeSci Biotech Products ETF (BBP)
NYSEARCA: BBP · IEX Real-Time Price · USD
55.20
-0.12 (-0.21%)
May 10, 2024, 4:00 PM EDT - Market closed
-0.21% (1D)
| Assets | $19.36M |
| Expense Ratio | 0.79% |
| PE Ratio | n/a |
| Shares Out | 350,004 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +1.54% |
| Volume | 1,879 |
| Open | 55.72 |
| Previous Close | 55.31 |
| Day's Range | 55.20 - 55.72 |
| 52-Week Low | 45.00 |
| 52-Week High | 63.25 |
| Beta | 0.89 |
| Holdings | 55 |
| Inception Date | Dec 17, 2014 |
About BBP
Fund Home PageThe Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.
Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol BBP
ETF Provider Virtus Investment Partners
Index Tracked LifeSci Biotechnology Products Index
Top 10 Holdings
29.55% of assets| Name | Symbol | Weight |
|---|---|---|
| ADMA Biologics, Inc. | ADMA | 4.29% |
| Tarsus Pharmaceuticals, Inc. | TARS | 3.81% |
| Deciphera Pharmaceuticals, Inc. | DCPH | 3.15% |
| Agios Pharmaceuticals, Inc. | AGIO | 2.79% |
| Sarepta Therapeutics, Inc. | SRPT | 2.74% |
| Lexicon Pharmaceuticals, Inc. | LXRX | 2.71% |
| Moderna, Inc. | MRNA | 2.69% |
| Ligand Pharmaceuticals Incorporated | LGND | 2.54% |
| Blueprint Medicines Corporation | BPMC | 2.51% |
| SpringWorks Therapeutics, Inc. | SWTX | 2.32% |
News
Late-stage biotech ETFs rally Monday on virus treatment hopes
Late-stage biotech exchange-traded funds were among the day's biggest gainers Monday as investors pinned their hopes on medical responses to the novel coronavirus. The ALPS Medical Breakthroughs ETF ...
Other symbols: SBIO
4 years ago - Market Watch